Tony Hodges
Chief Tech/Sci/R&D Officer presso LA JOLLA PHARMACEUTICAL COMPANY
Profilo
Tony Hodges is currently the Chief Medical Officer at La Jolla Pharmaceutical Co. Prior to this, he worked as the Director of Lung Transplantation at The Banner-University Medical Center from 2016 to 2020.
He also served as the Medical Director of Lung Transplantation at Keck Medicine of USC and Norton Thoracic Institute.
Mr. Hodges received his undergraduate degree from Louisiana Tech University and his doctorate from LSU Medical School.
Posizioni attive di Tony Hodges
Società | Posizione | Inizio |
---|---|---|
LA JOLLA PHARMACEUTICAL COMPANY | Chief Tech/Sci/R&D Officer | 12/09/2021 |
Precedenti posizioni note di Tony Hodges
Società | Posizione | Fine |
---|---|---|
The Banner-University Medical Center | Corporate Officer/Principal | 01/01/2020 |
Keck Medicine of USC | Corporate Officer/Principal | - |
Norton Thoracic Institute | Corporate Officer/Principal | - |
Formazione di Tony Hodges
Louisiana Tech University | Undergraduate Degree |
Lsu Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Norton Thoracic Institute |
- Borsa valori
- Insiders
- Tony Hodges